RBI
RVMD icon

Raiffeisen Bank International’s Revolution Medicines RVMD Stock Holding History

Raiffeisen Bank International’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Sell
20,101
-5,899
-23% -$862K 0.05% 219
2026
Q1 		$2.41M Sell
26,000
-3,000
-10% -$303K 0.03% 255
2025
Q4 		$2.31M Buy
29,000
+9,000
+45% +$590K 0.03% 240
2025
Q3 		$921K Buy
+20,000
New +$783K 0.01% 344

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Raiffeisen Bank International's RVMD Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Revolution Medicines (RVMD) stake by 23% in Q2 2026, selling an estimated $862K and leaving 20,101 shares worth $3.87M. The position accounts for 0.05% of the portfolio, ranked #219.

Raiffeisen Bank International first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Raiffeisen Bank International held 20,101 shares of Revolution Medicines worth $3.87M as of Q2 2026.
  • Raiffeisen Bank International sold 5,899 Revolution Medicines shares in Q2 2026, an estimated $862K.
  • Revolution Medicines made up 0.05% of Raiffeisen Bank International's portfolio in Q2 2026, its #219 holding.
  • Raiffeisen Bank International first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.